Tokyo, Japan

Koichi Shudo

USPTO Granted Patents = 55 

 

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 357(Granted Patents)

Forward Citations (Not Self Cited) = 325(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Totsukaku, Yokohama, JP (1980)
  • Yokohamashi, Kanagawa, JP (1981)
  • Kosugayacho, Totsukaku, Yokohamashi, Kanagawa, JP (1982)
  • Totsukaku, Yokohamashi, Kanagawa, JP (1981 - 1983)
  • Higashiyama, Meguroku Tokyo, JP (1987)
  • Mishuku-jutaku Higashiyama, Meguro-ku, Tokyo, JP (1987)
  • Higashiyama, Meguroku, Tokyo, JP (1988)
  • Higashiyama, Megura-ku, Tokyo, JP (1995)
  • Suginami-ku, Tokyo, JP (1997)
  • Suginami-ku, Tokyo JP (1998)
  • Tokyo-to, JP (2013)
  • Tokyo, JP (1989 - 2019)

Company Filing History:


Years Active: 1980-2019

Loading Chart...
Loading Chart...
55 patents (USPTO):Explore Patents

Title: **Koichi Shudo: Innovator in Neuropathic Disease Treatment**

Introduction

Koichi Shudo, based in Tokyo, Japan, is a prominent inventor known for his significant contributions to the field of medicinal treatments. With an impressive portfolio of 55 patents, Shudo has dedicated his career to developing innovative solutions for healthcare challenges, particularly in neuropathic diseases.

Latest Patents

Among his latest innovations is a medicament designed for the therapeutic treatment of neuropathic diseases. This medicament is formulated as an external preparation aimed at alleviating local symptoms associated with neuropathic conditions, utilizing either gabapentin or pregabalin in the form of an aqueous solution. His dual patent on this treatment highlights the effectiveness and importance of his work in addressing complex health conditions.

Career Highlights

Throughout his career, Shudo has worked at various reputable companies, including Kemphys Ltd. His extensive experience in the pharmaceutical industry has enabled him to refine his research and development skills, leading to groundbreaking inventions in the field of medicine.

Collaborations

Collaboration has been a key aspect of Shudo's career, working alongside talented professionals such as Katsuyoshi Iwamatsu and Yasuo Sato. These partnerships have fostered an environment of creativity and innovation, allowing for the development of effective treatments that benefit many patients.

Conclusion

Koichi Shudo continues to be a driving force in the development of therapeutic treatments for neuropathic diseases. His commitment to innovation is evident in his extensive patent portfolio and collaborative efforts with other skilled professionals. As the landscape of medical treatment evolves, Shudo's contributions remain vital to the advancement of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…